Original Source(s)
Related Content
Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation
by Xue Guan, Zhongyan Li, Huan Cheng, Jingru Li, Najie Wen, Luqiao Wang
July 21, 2026
Interpretable machine learning for presurgical differentiation of Hürthle cell carcinoma and adenoma: a SHAP-augmented approach
by Junyu Cao, Jing Li, Chuancheng Zhou, Jie Zhou, Kunxian Yang
July 20, 2026
Can Patients Switch to Biosimilar Aflibercept?
A 20-week INSIGHT extension suggests that switching from reference aflibercept to MYL-1701P maintained comparable safety, visual, and anatomic outcomes in patients with diabetic macular edema.
July 20, 2026
-
3 min